Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Cardio Diagnostics Holdings Inc., 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Astrana Health Inc. | Shares withheld for tax | −9,889 | $37.00 | $365,893 |
| Sep 5, 2026 | Astrana Health Inc. | Shares withheld for tax | −7,163 | $38.47 | $275,561 |
| Jun 27, 2026 | Astrana Health Inc. | Shares withheld for tax | −1,093 | $44.51 | $48,649 |
| Apr 6, 2026 | Astrana Health Inc. | Grant or award | +201,056 | — | — |
| Feb 2, 2026 | Astrana Health Inc. | Option exercise | +21,334 | $23.24 | $495,802 |
| Mar 5, 2025 | Astrana Health Inc. | Grant or award | +145,642 | — | — |
| Mar 5, 2025 | Astrana Health Inc. | Shares withheld for tax | −105,795 | $27.19 | $2,876,566 |
| Nov 8, 2024 | Astrana Health Inc. | Grant or award | +34,386 | — | — |
| Oct 2, 2024 | Astrana Health Inc. | Shares withheld for tax | −2,626 | $57.87 | $151,967 |
| Apr 2, 2024 | Astrana Health Inc. | Grant or award | +86,305 | — | — |
| Mar 29, 2024 | Astrana Health Inc. | Shares withheld for tax | −37,957 | $41.99 | $1,593,814 |
| Dec 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +5,020 | $2.49 | $12,500 |
| Sep 30, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +36,765 | $0.34 | $12,500 |
| Jun 30, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +21,008 | $1.19 | $25,000 |
| May 16, 2023 | Astrana Health Inc. | Grant or award | +380,053 | — | — |
Questions about Brandon Sim
What boards is Brandon Sim on?
Brandon Sim sits on the board of Cardio Diagnostics Holdings Inc.
How long has Brandon Sim served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.